BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30744630)

  • 1. Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study.
    von Siemens SM; Jörres RA; Behr J; Alter P; Lutter J; Lucke T; Söhler S; Welte T; Watz H; Vogelmeier CF; Trudzinski F; Rief W; Herbig B; Kahnert K;
    Respir Res; 2019 Feb; 20(1):30. PubMed ID: 30744630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.
    Wacker ME; Jörres RA; Karch A; Koch A; Heinrich J; Karrasch S; Schulz H; Peters A; Gläser S; Ewert R; Baumeister SE; Vogelmeier C; Leidl R; Holle R;
    Respir Res; 2016 Jul; 17(1):81. PubMed ID: 27405652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The revised GOLD 2017 COPD categorization in relation to comorbidities.
    Kahnert K; Alter P; Young D; Lucke T; Heinrich J; Huber RM; Behr J; Wacker M; Biertz F; Watz H; Bals R; Welte T; Wirtz H; Herth F; Vestbo J; Wouters EF; Vogelmeier CF; Jörres RA
    Respir Med; 2018 Jan; 134():79-85. PubMed ID: 29413512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of suicide ideation in patients with COPD: a mixed methods study.
    Fleehart S; Fan VS; Nguyen HQ; Lee J; Kohen R; Herting JR; Matute-Bello G; Adams SG; Pagalilauan G; Borson S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1321-9. PubMed ID: 25587219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of frailty in primary care patients with COPD: the Greek UNLOCK study.
    Ierodiakonou D; Kampouraki M; Poulonirakis I; Papadokostakis P; Lintovoi E; Karanassos D; Maltezis K; Chorti M; Petrovitsos E; Dimopoulou S; Hamind S; Gialamas I; Athanasiou P; Bempi V; Lambraki I; Tsiligianni I
    BMC Pulm Med; 2019 Mar; 19(1):63. PubMed ID: 30876423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease.
    Chang CH; Chuang LP; Lin SW; Lee CS; Tsai YH; Wei YF; Cheng SL; Hsu JY; Kuo PH; Yu CJ; Chen NH
    BMC Pulm Med; 2016 Aug; 16(1):118. PubMed ID: 27501837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the prevalence of depression and the severity of depression in patients of chronic obstructive pulmonary disease in a semi-urban Indian population.
    Agarwal A; Batra S; Prasad R; Verma A; Jilani AQ; Kant S
    Monaldi Arch Chest Dis; 2018 Mar; 88(1):902. PubMed ID: 29557571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of depression before and after inpatient rehabilitation in COPD patients: Psychometric properties of the German version of the Patient Health Questionnaire (PHQ-9/PHQ-2).
    Schuler M; Strohmayer M; Mühlig S; Schwaighofer B; Wittmann M; Faller H; Schultz K
    J Affect Disord; 2018 May; 232():268-275. PubMed ID: 29499510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
    Frantzi N; Nguyen XP; Herr C; Alter P; Söhler S; Soriano D; Watz H; Waschki B; Trinkmann F; Eichenlaub M; Trudzinski FC; Michels-Zetsche JD; Omlor A; Seiler F; Moneke I; Biertz F; Rohde G; Stolz D; Welte T; Kauczor HU; Kahnert K; Jörres RA; Vogelmeier CF; Bals R; Fähndrich S;
    Respir Res; 2024 May; 25(1):207. PubMed ID: 38750572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline.
    Karch A; Vogelmeier C; Welte T; Bals R; Kauczor HU; Biederer J; Heinrich J; Schulz H; Gläser S; Holle R; Watz H; Korn S; Adaskina N; Biertz F; Vogel C; Vestbo J; Wouters EF; Rabe KF; Söhler S; Koch A; Jörres RA;
    Respir Med; 2016 May; 114():27-37. PubMed ID: 27109808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities.
    Trudzinski FC; Kellerer C; Jörres RA; Alter P; Lutter JI; Trinkmann F; Herth FJF; Frankenberger M; Watz H; Vogelmeier CF; Kauczor HU; Welte T; Behr J; Bals R; Kahnert K
    Clin Res Cardiol; 2023 Feb; 112(2):177-186. PubMed ID: 34331588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
    Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.
    Wacker ME; Jörres RA; Karch A; Wilke S; Heinrich J; Karrasch S; Koch A; Schulz H; Watz H; Leidl R; Vogelmeier C; Holle R;
    BMC Pulm Med; 2016 May; 16(1):70. PubMed ID: 27160582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort.
    von Siemens SM; Perneczky R; Vogelmeier CF; Behr J; Kauffmann-Guerrero D; Alter P; Trudzinski FC; Bals R; Grohé C; Söhler S; Waschki B; Lutter JI; Welte T; Jörres RA; Kahnert K;
    Respir Res; 2019 Nov; 20(1):257. PubMed ID: 31727165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities and COPD severity in a clinic-based cohort.
    Raherison C; Ouaalaya EH; Bernady A; Casteigt J; Nocent-Eijnani C; Falque L; Le Guillou F; Nguyen L; Ozier A; Molimard M
    BMC Pulm Med; 2018 Jul; 18(1):117. PubMed ID: 30012144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.